GSK seeks FDA approval for Fluarix flu vaccine

05/26/2005 | Forbes

GlaxoSmithKline said it has applied for FDA approval for its Fluarix flu vaccine, appealing to the agency to allow it to supply the U.S. market, where there is expected to be another shortage of the shots in the next season. GSK already markets Fluarix in more than 75 other countries, but said it could provide as many as 10 million shots for the U.S. market if the FDA gives its approval.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY